BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16232302)

  • 1. Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance.
    Campioni M; Santini D; Tonini G; Murace R; Dragonetti E; Spugnini EP; Baldi A
    Exp Dermatol; 2005 Nov; 14(11):811-8. PubMed ID: 16232302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APAF-1 signaling in human melanoma.
    Anichini A; Mortarini R; Sensi M; Zanon M
    Cancer Lett; 2006 Jul; 238(2):168-79. PubMed ID: 16095810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Big wheel keeps on turning: apoptosome regulation and its role in chemoresistance.
    Fadeel B; Ottosson A; Pervaiz S
    Cell Death Differ; 2008 Mar; 15(3):443-52. PubMed ID: 17975549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of apaf-1 in melanoma drug resistance and apoptosis.
    Röckmann H; Schadendorf D
    J Invest Dermatol; 2005 Aug; 125(2):386-7. PubMed ID: 16098052
    [No Abstract]   [Full Text] [Related]  

  • 5. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.
    Soengas MS; Capodieci P; Polsky D; Mora J; Esteller M; Opitz-Araya X; McCombie R; Herman JG; Gerald WL; Lazebnik YA; Cordón-Cardó C; Lowe SW
    Nature; 2001 Jan; 409(6817):207-11. PubMed ID: 11196646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apaf-1 expression in malignant melanoma.
    Soengas MS; Gerald WL; Cordon-Cardo C; Lazebnik Y; Lowe SW
    Cell Death Differ; 2006 Feb; 13(2):352-3. PubMed ID: 16110320
    [No Abstract]   [Full Text] [Related]  

  • 7. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
    Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
    J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of APAF-1 expression in human cutaneous melanoma progression.
    Baldi A; Santini D; Russo P; Catricalà C; Amantea A; Picardo M; Tatangelo F; Botti G; Dragonetti E; Murace R; Tonini G; Natali PG; Baldi F; Paggi MG
    Exp Dermatol; 2004 Feb; 13(2):93-7. PubMed ID: 15009102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants in Apaf-1 segregating with major depression promote apoptosome function.
    Harlan J; Chen Y; Gubbins E; Mueller R; Roch JM; Walter K; Lake M; Olsen T; Metzger P; Dorwin S; Ladror U; Egan DA; Severin J; Johnson RW; Holzman TF; Voelp K; Davenport C; Beck A; Potter J; Gopalakrishnan M; Hahn A; Spear BB; Halbert DN; Sullivan JP; Abkevich V; Neff CD; Skolnick MH; Shattuck D; Katz DA
    Mol Psychiatry; 2006 Jan; 11(1):76-85. PubMed ID: 16231040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.
    Eberle J; Kurbanov BM; Hossini AM; Trefzer U; Fecker LF
    Drug Resist Updat; 2007 Dec; 10(6):218-34. PubMed ID: 18054518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular K(+) inhibits apoptosis by suppressing the Apaf-1 apoptosome formation and subsequent downstream pathways but not cytochrome c release.
    Karki P; Seong C; Kim JE; Hur K; Shin SY; Lee JS; Cho B; Park IS
    Cell Death Differ; 2007 Dec; 14(12):2068-75. PubMed ID: 17885667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway.
    Teng X; Sakai T; Liu L; Sakai R; Kaji R; Fukui K
    J Neurochem; 2006 May; 97(4):1126-35. PubMed ID: 16686692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibitors of Apaf-1-related caspase- 3/-9 activation that control mitochondrial-dependent apoptosis.
    Malet G; Martín AG; Orzáez M; Vicent MJ; Masip I; Sanclimens G; Ferrer-Montiel A; Mingarro I; Messeguer A; Fearnhead HO; Pérez-Payá E
    Cell Death Differ; 2006 Sep; 13(9):1523-32. PubMed ID: 16341125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma.
    Hersey P
    Curr Opin Oncol; 2006 Mar; 18(2):189-96. PubMed ID: 16462190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in breast cancer cells.
    Schafer ZT; Parrish AB; Wright KM; Margolis SS; Marks JR; Deshmukh M; Kornbluth S
    Cancer Res; 2006 Feb; 66(4):2210-8. PubMed ID: 16489023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular nucleotides act as critical prosurvival factors by binding to cytochrome C and inhibiting apoptosome.
    Chandra D; Bratton SB; Person MD; Tian Y; Martin AG; Ayres M; Fearnhead HO; Gandhi V; Tang DG
    Cell; 2006 Jun; 125(7):1333-46. PubMed ID: 16814719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase activity regulates apaf-1 and caspase 3 expression in the developing mouse retina.
    Wallace DM; Donovan M; Cotter TG
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2765-72. PubMed ID: 16799012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium blocks formation of apoptosome by preventing nucleotide exchange in Apaf-1.
    Bao Q; Lu W; Rabinowitz JD; Shi Y
    Mol Cell; 2007 Jan; 25(2):181-92. PubMed ID: 17244527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apaf-1 expression in human cutaneous melanoma progression and in pigmented nevi.
    Niedojadło K; Łabedzka K; Łada E; Milewska A; Chwirot BW
    Pigment Cell Res; 2006 Feb; 19(1):43-50. PubMed ID: 16420245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of the apoptosis effector Apaf-1 in melanoma.
    Peltenburg LT; de Bruin EC; Meersma D; Smit NP; Schrier PI; Medema JP
    Cell Death Differ; 2005 Jun; 12(6):678-9. PubMed ID: 15832175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.